Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

(2013) Ole Haagen Nielsen et al.   BMC Medicine

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

(2012) Gert Van Assche et al.   Journal of Crohns & Colitis

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006

(2011) A. Bortoli et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics

(2010) Uma Mahadevan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

European evidenced-based consensus on reproduction in inflammatory bowel disease

(2010) C. Janneke van der Woude et al.   Journal of Crohns & Colitis

142 Pregnancy Outcomes in Women Exposed to Adalimumab: the OTIS Autoimmune Diseases in Pregnancy Project

(2009) Diana L. Johnson et al.   GASTROENTEROLOGY

Certolizumab use in pregnancy

(2009) A Oussalah et al.   GUT

Safety of Adalimumab in Crohnʼs Disease During Pregnancy: Case Report and Review of the Literature

(2009) Matthias Jürgens et al.   INFLAMMATORY BOWEL DISEASES

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Outcomes of Obstetric Hospitalizations Among Women With Inflammatory Bowel Disease in the United States

(2008) Geoffrey C. Nguyen et al.   Clinical Gastroenterology and Hepatology